{"id":"W1980420833","doi":"10.1016/j.ahj.2012.12.015","title":"Ambulance or in-catheterization laboratory administration of ticagrelor for primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Rationale and design of the randomized, double-blind Administration of Ticagrelor in the cath Lab or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) study","year":2013,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Canadian Heart Research Centre; Southlake Regional Health Center","funders":"Servier; Société Française de Cardiologie; Fédération Française de Cardiologie; Institut National de la Santé et de la Recherche Médicale; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Ticagrelor; Percutaneous coronary intervention; Conventional PCI; Myocardial infarction; Internal medicine; Cardiology; Randomized controlled trial; Clinical endpoint; Thrombolysis; Prasugrel; Clopidogrel; Placebo; ST elevation; TIMI","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009098281,0.002720256,0.005132041,0.000713742,0.001111279,0.001974803,0.001403384,0.002838644,0.006024507],"category_scores_gemma":[0.009978198,0.001518525,0.002770431,0.0008530765,0.003339952,0.001367256,0.0008294252,0.005314677,0.001313611],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007548102,"about_ca_system_score_gemma":0.002490996,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008441432,"about_ca_topic_score_gemma":0.001736588,"domain_scores_codex":[0.9915875,0.005677972,0.0006913742,0.0008978237,0.0004975419,0.0006477484],"domain_scores_gemma":[0.9951224,0.001706849,0.001047572,0.0007202412,0.00047539,0.0009276218],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9799041,0.009034559,0.001480825,0.0005296989,0.001260224,0.00001930729,0.00006832512,0.0001783997,0.00148786,0.0005069516,0.0003205232,0.005209196],"study_design_scores_gemma":[0.943196,0.05053968,0.002340622,0.00005035388,0.001293793,0.00001857836,0.00003432154,0.0004321452,0.0004898733,0.0005406727,0.001037523,0.00002641163],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.902478,0.00623067,0.007122937,0.001603457,0.002687119,0.068927,0.002278951,0.0001872178,0.008484647],"genre_scores_gemma":[0.9228181,0.003042543,0.0121025,0.002023497,0.002130297,0.05384588,0.001110303,0.00005768864,0.002869129],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.009098281,"threshold_uncertainty_score":0.04811686,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04479559503326706,"score_gpt":0.3230565785610634,"score_spread":0.2782609835277963,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}